Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction
Objective: To investigate the effects of atorvastatin calcium on the inflammatory factors and fibrinolytic system in patients with acute cerebral infarction. Methods: A total of 170 inpatients with acute cerebral infarction in Neurological department of our hospital between December 2014 and Decem...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2016-08-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/201616/38.pdf |
id |
doaj-1ce3891c186d404dad0edf20c4fff3fe |
---|---|
record_format |
Article |
spelling |
doaj-1ce3891c186d404dad0edf20c4fff3fe2020-11-25T00:19:33ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12371007-12372016-08-012216146149Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarctionDe-Ning Guan0Ya-nan Hu1Yang Zhang2Yun Luo3Neurological Department of Gulou Hospital Affiliated to Medical College of Nanjing University, Nanjing, Jiangsu 210008Neurological Department of Gulou Hospital Affiliated to Medical College of Nanjing University, Nanjing, Jiangsu 210008Neurological Department of Gulou Hospital Affiliated to Medical College of Nanjing University, Nanjing, Jiangsu 210008Neurological Department of Gulou Hospital Affiliated to Medical College of Nanjing University, Nanjing, Jiangsu 210008Objective: To investigate the effects of atorvastatin calcium on the inflammatory factors and fibrinolytic system in patients with acute cerebral infarction. Methods: A total of 170 inpatients with acute cerebral infarction in Neurological department of our hospital between December 2014 and December 2015 were selected as Subjects in the study, and randomly divided into intensive lipid-lowering therapy group (85 cases) and control group (85 cases). before the treatment, FPG, HbA1c (%), TG, TCH and LDL-C, HDL-C in patients were detected. hs-CRP, IL-6, IL-8, IL-10, TNF-α in serum, and PAI-1, t-PA, FIB in plasma were detected and compared between before treatment and 8 weeks after the treatment. Results: patients with acute cerebral infarction in intensive lipid-lowering therapy group and control group showed no significant difference in inflammatory factors (hs-CRP, IL-6, IL-8, IL- 10, TNF-α) and fibrinolytic system (PAI-1, t-PA, FIB) before treatment. After eight weeks of treatment, hs-CRP, IL-6, IL-8, TNF-α, PAI-1 and FIB in patients in both groups were lower than that before treatment, and had statistical difference. IL-10, t-PA was increased than that before treatment and also had significant difference. In intensive lipid-lowering therapy group, the variation ranges of hs-CRP, IL-6, IL-8, IL-10, TNF-α, PAI-1, t-PA and FIB were greater than that of the control group, and were statistically different. Conclusion: Atorvastatin calcium, the intensive lipid-lowering therapy, can reduce hs-CRP, IL-6, IL-8, TNF-a, PAI-1, FIB levels significantly in the acute cerebral infarction patients, and elevate levels of IL-10 and t-PA in serum. It has the effect on inhibiting inflammation and regulating the fibrinolytic activity.http://www.hnykdxxb.com/PDF/201616/38.pdfAtorvastatinIntensive lipid-loweringAcute cerebral infarctionInflammatory factors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
De-Ning Guan Ya-nan Hu Yang Zhang Yun Luo |
spellingShingle |
De-Ning Guan Ya-nan Hu Yang Zhang Yun Luo Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction Journal of Hainan Medical University Atorvastatin Intensive lipid-lowering Acute cerebral infarction Inflammatory factors |
author_facet |
De-Ning Guan Ya-nan Hu Yang Zhang Yun Luo |
author_sort |
De-Ning Guan |
title |
Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction |
title_short |
Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction |
title_full |
Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction |
title_fullStr |
Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction |
title_full_unstemmed |
Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction |
title_sort |
effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction |
publisher |
Editorial Board of Journal of Hainan Medical University |
series |
Journal of Hainan Medical University |
issn |
1007-1237 1007-1237 |
publishDate |
2016-08-01 |
description |
Objective: To investigate the effects of atorvastatin calcium on the inflammatory factors and
fibrinolytic system in patients with acute cerebral infarction. Methods: A total of 170 inpatients with acute cerebral infarction in Neurological department of our hospital between
December 2014 and December 2015 were selected as Subjects in the study, and randomly
divided into intensive lipid-lowering therapy group (85 cases) and control group (85 cases).
before the treatment, FPG, HbA1c (%), TG, TCH and LDL-C, HDL-C in patients were
detected. hs-CRP, IL-6, IL-8, IL-10, TNF-α in serum, and PAI-1, t-PA, FIB in plasma were
detected and compared between before treatment and 8 weeks after the treatment. Results:
patients with acute cerebral infarction in intensive lipid-lowering therapy group and control
group showed no significant difference in inflammatory factors (hs-CRP, IL-6, IL-8, IL-
10, TNF-α) and fibrinolytic system (PAI-1, t-PA, FIB) before treatment. After eight weeks of
treatment, hs-CRP, IL-6, IL-8, TNF-α, PAI-1 and FIB in patients in both groups were lower than
that before treatment, and had statistical difference. IL-10, t-PA was increased than that before
treatment and also had significant difference. In intensive lipid-lowering therapy group, the
variation ranges of hs-CRP, IL-6, IL-8, IL-10, TNF-α, PAI-1, t-PA and FIB were greater than
that of the control group, and were statistically different. Conclusion: Atorvastatin calcium,
the intensive lipid-lowering therapy, can reduce hs-CRP, IL-6, IL-8, TNF-a, PAI-1, FIB levels
significantly in the acute cerebral infarction patients, and elevate levels of IL-10 and t-PA in
serum. It has the effect on inhibiting inflammation and regulating the fibrinolytic activity. |
topic |
Atorvastatin Intensive lipid-lowering Acute cerebral infarction Inflammatory factors |
url |
http://www.hnykdxxb.com/PDF/201616/38.pdf |
work_keys_str_mv |
AT deningguan effectofintensivelipidloweringtherapyoninflammatoryfactorsandfibrinolyticsysteminpatientswithacutecerebralinfarction AT yananhu effectofintensivelipidloweringtherapyoninflammatoryfactorsandfibrinolyticsysteminpatientswithacutecerebralinfarction AT yangzhang effectofintensivelipidloweringtherapyoninflammatoryfactorsandfibrinolyticsysteminpatientswithacutecerebralinfarction AT yunluo effectofintensivelipidloweringtherapyoninflammatoryfactorsandfibrinolyticsysteminpatientswithacutecerebralinfarction |
_version_ |
1725371418362773504 |